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Abstract 
Background- Dicer endonuclease, critical for maturation of microRNAs (miRNAs), is depleted 
in heart failure patients with certain forms of cardiomyopathy. We sought to elucidate the 
mechanisms underlying the rapid loss of cardiac function following cardiac-specific Dicer 
deletion in adult mice. Methods and Results- Conditional Dicer deletion was achieved by a 
tamoxifen-inducible Cre recombinase in the adult murine myocardium. Heart function, 
determined using MRI and echocardiography, showed rapid and significant (p<0.05, n=5) 
decrease in fractional shortening, compromised ejection fraction, and increased left ventricular 
mass. Decreased respiratory control ratio (RCR) noted in isolated heart mitochondria (p<0.05, 
n=5), faster nitroxide radical decay in EPR spectroscopy (p<0.05, n=3), along with elevated lipid 
peroxidation (p<0.05, n=3), glutathione oxidation (p<0.05, n=4) and lactate (p<0.05, n=4) 
indicated mitochondrial dysfunction and oxidant stress. Microarray and QPCR detected early 
onset changes in 22 miRNAs (p<0.05, n=3) including elevated miRNA-15b.  Over expression of 
miRNA15b in cardiomyocytes, resulted in compromised mitochondrial membrane potential 
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(measured by TMRM fluorescence and JC-1 flow cytometry, p<0.05, n=4). Conclusions- Acute 
depletion of Dicer in adult mice results in miRNA-15b dependent mitochondrial dysfunction and 
oxidative stress which is followed by rapid loss of cardiac function.  
INTRODUCTION 
Dicer depletion resulting in arrest of microRNA (miRNA) maturation is known to perturb 
cardiac development1-2 and cause pathological consequences3-4. Significance of such 
observations is heightened by the report that Dicer deficiency is associated with specific forms of 
cardiomyopathy and heart failure in humans4. We sought to develop first understanding of the 
pivotal pathways that initiate cardiac hypertrophy and failure in response to targeted Dicer 
deletion in the adult murine heart. Our strategy has been to delineate primary causative 
mechanisms by focusing on early onset changes in the adult heart following Dicer deletion, with 
the goal to be able to rescue using miRNA-directed intervention. This approach resulted in the 
identification of elevated miRNA-15b in the heart as a causative factor. Taken together with the 
observation that most types of human heart failure are associated with elevated miRNA-15b5-6, 
our findings recognize suppression of inducible miRNA-15b as a key approach worthy of 
therapeutic consideration.  
MATERIALS AND METHODS 
Development of the transgenic mice. Mice homozygous for Dicer-floxed (loxP) alleles and 
transgenic B6129-Tg (Myh6-cre/Esr1)1Jmk/J were crossed to generate double transgenic 
(Myh6-cre/Esr1-Dicerfl/fl) mice. Adult male mice at 8 weeks of age (Myh6-cre/Esr1-Dicerfl/fl and 
control Dicerfl/fl) were treated with vehicle (10%/90% vol/vol ethanol/corn oil) or tamoxifen 
(20mg/kg body weight per day diluted in 10%/90% vol/vol ethanol/corn oil) by daily 
intraperitoneal injections for consecutive 5 days. Measurement of cardiac function. MRI and 
  
- 3 - 
echocardiography image acquisition and analysis was performed on all mice at the age of 8 
weeks (17-21g) as described previously7. miRNA profiling. Total RNA including miRNA was 
isolated using mirVana™ miRNA isolation kit and comprehensive profiling of all the mouse/rat 
miRs annotated in the miRBase 8.0 was performed using the FlexmiR™ MicroRNA Labeling 
Kit and the Luminex 200 analyzer system. Combined miRNA / total RNA isolation and 
reverse transcription. Total RNA, including miRNA, was isolated using mirVana™ miRNA 
isolation kit. Specific Taqman assays for miRNA and mirVana qRT-PCR miRNA RT Kit were 
used with real-time PCR system and Taqman universal master mix. Levels of miRNA were 
quantified with the relative quantification method using snoRNA202 as the housekeeping 
miRNA. Measurement of in vivo tissue redox status with localized electron paramagnetic 
resonance (EPR). In vivo tissue redox status was determined by EPR as described previously 
with modifications8. Briefly, 2, 2, 5, 5-tetramethyl-3-carboxylpyrrolidine-Noxyl (PCA) was 
employed as the spin probe to generate a three-line EPR spectrum. The nitroxide solutions were 
prepared in PBS and kept frozen until use. PCA solution (10 mM, 20 µl) was intramuscularly 
injected into the left ventricular region. EPR spectra were acquired with a surface loop resonator 
placed on top of the heart. The lower field peak-height was monitored with time to determine the 
rate of probe reduction. TBARS assay. As a marker of lipid peroxidation in the myocardial 
tissue, malondialdehyde (MDA) levels were detected by the thiobarbituric acid reactive 
substances (TBARS) method as reported previously9 with some modifications (details in 
supplementary text). Reduced (GSH) and oxidized (GSSG) glutathione assay. GSH and 
GSSG were detected in the heart tissues using an HPLC coulometric electrode array detector 
(CoulArray Detector, model 5600 with 12 channels; ESA Inc., Chelmsford, MA, USA) as 
described previously10-12. Lactate measurement. Mice were euthanized; hearts were dissected 
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out and homogenized in the assay buffer provided with the Lactate Assay Kit (Biovision). Assay 
for lactate was done according to the protocol provided with the kit. Preparation and 
incubation of mitochondria and measurement of respiration. Mitochondria extraction was 
done as published previously13 with modifications. Respiration rates of cardiac mitochondria 
were determined immediately following isolation using a Clark oxygen electrode and an oxygen 
monitor (Yellow Springs Instrument, Yellow Springs, OH) as previously described14 with slight 
modifications. All measurements were completed within 1 h. Succinate (10mM) was used as 
substrate. State 3 respiration rates (ADP-dependent oxygen consumption) were determined 
following the addition of 200 µM ADP, whereas the rates measured following the consumption 
of ADP as it was converted to ATP were taken as the state 4 respiration rates (ADP-independent 
oxygen consumption). Respiratory Control Ratio (RCR) was calculated as a ratio of State 3 to 
State 4 respiration. Cell culture. Murine HL1 cardiomyocytes15 were cultured in flasks coated 
with 12.5µg/ml fibronectin and 0.02% gelatin maintained in Complete Claycomb Medium 
supplemented with 100µM norepinephrine (consisting of 10mM Norepinephrine dissolved in 0.3 
mM L-ascorbic acid), 4mM L-glutamine, 10% fetal calf serum, 100 units/ml penicillin and 
100µg/ml streptomycin at 37ºC in a humidified atmosphere of 95% air and 5% CO2. MiRNA 
delivery to cells. Transfection of HL-1 cardiomyocytes was performed as described16. Briefly, 
HL-1 cells (0.15 × 106 cells per well in 12-well plate) were seeded in antibiotic-free 
supplemented Claycomb medium 24 h before transfection. DharmaFECT 1 transfection reagent 
was used to transfect cells with hsa-miRNA-15b mimic as per the manufacturer’s instructions. 
Transfection of miRNA mimic negative controls was performed for the control groups. Cells 
were harvested after 72 h of such treatment. Measurement of mitochondrial membrane 
potential (∆Ψ). JC-1 assay Mitochondrial membrane potential changes were assessed using the 
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lipophilic cationic dye JC-1 as reported previously17. Results (percentage of negative cells) were 
normalized to either non-transfected cells or cells transfected with the scrambled mimic control 
while CCCP treated cells were used as a positive control. TMRM assay Mitochondrial membrane 
∆Ψ was measured using the fluorescent lipophilic cationic dye TMRM, which accumulates 
within mitochondria in a potential dependent manner18. HL1 cells transfected with mir-15b 
mimic and after 72 h were reseeded on glass coverslips. Following 24 h of re-seeding, the cells 
were stained with 8 nM TMRM and 0.5 ml/ml plasma membrane potential indicator (PMPI) for 
30 min at 37ºC in the dark. Cells were washed with PBS, and digital images of stained live cells 
were collected using a Zeiss Axiovert 200M microscope19. Western blots. Western blot was 
performed as described previously20-22. Primary antibodies against Dicer (1:400), Pim1 (1:500) 
and GAPDH (1:10,000) were used to detect these antigens. Statistical analyses. Data are 
reported as mean ± S.D. of at least three independent experiments as indicated in respective 
figure legends. Difference between means was tested by Student’s t-test. Comparisons between 
multiple groups were made by analysis of variance. p<0.05 was considered statistically 
significant. 
RESULTS 
Cardiac specific Dicer deletion leads to cardiac hypertrophy and impaired cardiac function 
To develop double transgenic Myh6-cre/Esr1-Dicerfl/fl mice, floxed Dicer allele23 were bred with 
mice expressing a tamoxifen-inducible Cre recombinase protein flanked on each end with a 
mutated murine estrogen receptor ligand binding domain, under the control of the cardiac-
specific murine alpha-myosin heavy chain (Myh6) promoter. Intraperitoneal tamoxifen injection 
(once daily, 5 consecutive days) to adult mice activated Cre recombinase resulting in Dicer null 
mice (Dicer-/-). The control set (Dicer+/+) was generated by injecting littermates with equivalent 
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amount of vehicle (ethanol/corn oil) (Figure. 1A). Within 7 days from the start of tamoxifen 
delivery, Dicer protein was reduced by 70% (Figure 1B) and Dicer-/- mice displayed impaired 
gait and inactivity compared with Dicer+/+ mice. Such evidence was not noted in wild-type mice 
injected with matched dose of tamoxifen (not shown). Targeted Dicer deletion in the adult 
murine heart resulted in increased left ventricular myocardial mass and compromised cardiac 
function as determined by 11.7T MRI and M-mode echocardiography (Figure 1C). Long and 
short axis serial MR images demonstrated enlarged diastole in Dicer-/- mice indicative of dilated 
cardiomyopathy (Figure 1D and E and supplementary movie 1 and 2). Objective assessment of 
the MRI and echocardiography data consistently demonstrated significant (p<0.05, n=5) decline 
in cardiac function as manifested by decreased fractional shortening and lower ejection fraction. 
Hypertrophy was indicated by a significant increase in the left ventricular mass and wall 
thickness (Figure 1F and G). Thus, Dicer deletion in 8 week old adult mice caused early onset (1 
week) hypertrophy and marked loss of cardiac function.  
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Figure 1. Conditional deletion of the mouse gene Dicer and measurement of cardiac 
functions. (A) Generation of Myh6-cre/Esr1-Dicerfl/fl mice. (B) Western Blot showing reduced 
Dicer expression following tamoxifen injection. (C) Representative M-mode images of Dicer+/+ 
and Dicer-/- mice. The data indicates decreased contractility and increased left ventricular (LV) 
internal dimensions in Dicer-/- mice (D) 11.7T MRI images of long axis at diastole (i & iii), 
systole (ii & iv) cardiac 11.7T MRI images in Dicer+/+ and Dicer-/- mice. The diastole of Dicer-/- 
mice was enlarged due to insufficient contraction of the heart (shown by arrows). (E) 11.7T 
images of short axis at diastole and systole of 1.0 mm slices stacked along columns from base to 
apex of the left ventricle of both Dicer+/+ and Dicer-/- mice. Blue contour lines indicate LV 
volume. Quantification of LV fractional shortening, LV myocardial mass, and LV ejection 
fraction (EF) by MRI (F) and ECHO (G). Data are expressed as mean ± SD (n=5). Data 
indicates decreased LV fractional shortening and EF and increased LV myocardial mass in 
Dicer-/- mice. Solid bars represent Dicer+/+ and open bars represent Dicer-/-. 
 
Cardiac specific Dicer deletion leads to early onset changes in specific miRNAs 
double-transgenic 
(Myh6-cre/Esr1-Dicerfl/fl) 
IP injection / 20mgs/kg 
tamoxifen for 5 days
transgenic Myh6-cre/Esr1 
Dicer+/+ Dicer-/-
IP injection
corn oil for 5 days
homozygous for Dicer-
floxed alleles (Dicerfl/fl) 
8 weeks old
A
C
C
Dicer +/+ Dicer -/-
(i) (ii)B
F
MRI
LV
 
fr
ac
tio
n
al
 
sh
o
rt
en
in
g 
(%
)
0
10
20
30
40
50
60
*
Dicer+/+ Dicer-/-
LV
 
fr
ac
tio
n
al
 
sh
o
rt
en
in
g 
(%
) ECHO
G
0
10
20
30
40
50
60
LV
 
fr
ac
tio
n
al
 
sh
o
rt
en
in
g 
(%
)
*
Dicer+/+ Dicer-/-
*
LV
 
m
yo
ca
rd
ia
l m
as
s 
(m
g)
0
40
50
60
70
80
90
Dicer+/+ Dicer-/-
LV
 
m
yo
ca
rd
ia
l m
as
s 
(m
g)
LV
 
m
yo
ca
rd
ia
l m
as
s 
(m
g)
0
40
50
60
70
80
90
*
Dicer+/+ Dicer-/-
LV
 
m
yo
ca
rd
ia
l m
as
s 
(m
g)
*
Dicer-/-0
40
50
60
70
80
90
100
LV
 
eje
ct
io
n
 
fr
ac
tio
n
 
(%
)
Dicer+/+
LV
 
eje
ct
io
n
 
fr
ac
tio
n
 
(%
)
*
LV
 
eje
ct
io
n
 
fr
ac
tio
n
 
(%
)
0
40
50
60
70
80
90
100
Dicer+/+ Dicer-/-
LV
 
eje
ct
io
n
 
fr
ac
tio
n
 
(%
)
Dicer-/-
(systole)
E
Dicer+/+
(diastole)
Dicer+/+
(systole)
Dicer-/-
(diastole)
base
apex
(i) diastole (ii) systole (iii) diastole (iv) systole
D
0
20
40
60
80
100
120
Dicer+/+ Dicer-/-
GAPDH
Dicer (255kD)
D
ic
er
/G
AP
DH
 
pr
o
te
in
 
(%
 
 
ch
an
ge
)
Fig 1
*
  
- 8 - 
MiRNA microarray studies identified a limited set of 22 miRNAs (out of 327 listed in miRbase 
8.0; 6.7%) which significantly changed (p<0.05, n=3) after the first week of tamoxifen injection 
when over 50% of cardiac function was already compromised. The strategy was to study an early 
time point so that the primary mediators of cardiac dysfunction could be unveiled. Of the 22 
candidate miRNAs identified, only 5 were elevated while 17 were down-regulated. Microarray 
results were confirmed using QPCR (Figure 2A-C). Of the miRNAs elevated following Dicer 
deletion, miRNA-15b was a key candidate predicted to target mitochondrial function as 
determined by TargetScanTM v 5.1 and PictarTM. Indeed, delivery of miR-15b to cardiomyocytes 
specifically compromised mitochondrial membrane potential (TMRM fluorescence) (Fig. 3A and 
B). Mitochondrial membrane potential changes assessed using the JC-1 assay demonstrated that 
over expression of miRNA-15b in cardiomyocytes compromised ∆Ψ (Fig. 3C and D).  
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Figure 2. Differential 
expression of miRNAs 
on targeted Dicer 
deletion. (A) Heat map 
generated for the 
differentially expressed 
miRNAs in Dicer+/+ and 
Dicer-/- mice. (B) 
Validation of selected 
miRNAs by real-time 
PCR showing (i) down 
regulated miRNAs and 
(ii) up regulated 
miRNAs in Dicer-/- 
(open bars) as opposed 
to Dicer+/+ (solid bars). 
Data are expressed as 
mean ± SD (n=5).  
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Figure 3. (A) Transfection of HL-1 cardiomyocytes with miRNA-15b mimic compromised 
mitochondrial membrane potential. HL-1 cells were transfected (72 hours) with mimic 
negative control or miRNA-15b mimic. Untransfected cells were used as negative control and 
cells transfected with carbonyl cyanide m-chlorophenylhydrazone (CCCP) were used as positive 
control (left panel – 8 nM tetramethylrhodamine methyl ester (TMRM); center panel - 0.5µl/ml 
plasma membrane potential indicator (PMPI); right panel - merged image). (B) Bar graph shows 
significant decrease in TMRM with no change in PMPI. Solid bars represent mimic negative 
control while open bars represent miRNA-15b mimic. (C) Loss of mitochondrial membrane 
potential in HL-1 cells transfected with miRNA-15b mimic, as assessed by JC-1 flow cytometry 
72 h post-transfection. Cells were transfected with a (i) mimic control, (ii) miRNA-15b mimic or 
(iii) treated with CCCP Arrows (K gate) indicate cells containing JC-1 aggregates resulting from 
intact mitochondria; M gate indicates cells with low or collapsed mitochondrial membrane 
potential. (D) Ratio of polarized to depolarized cells calculated as a ratio between cells in K gate 
to M gate. Data indicate decrease in membrane potential upon up-regulation of miRNA-15b. 
Data expressed as mean ± SD (n=3). 
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Dicer deletion in the adult heart led to mitochondrial dysfunction and oxidative stress  
Redox state of the Dicer deleted adult heart was determined by EPR spectroscopy. After  
intramuscular injection of 2, 2, 5, 5,-tetramethylpyrrolidine-1-oxyl-3-carboxylic acid (PCA) to 
the heart, decay of nitroxyl radicals was studied (Figures 4A and supplementary figure S1A-B). 
A faster decay in Dicer deleted hearts was seen that has been considered indicative of a higher 
abundance of reactive oxygen species8 (Figure 4B, p<0.05, n=3). This observation was 
consistent with elevated lipid peroxidation (Figure 4C; p<0.05, n=3) and glutathione oxidation 
(Figure 4D; p<0.05, n=4), indices of oxidative stress, in the hearts of Dicer-/- mice. These 
observations led to the hypothesis that the heart of Dicer-/- mice suffers from mitochondrial 
dysfunction resulting in oxidative stress. Analysis of respiration of isolated heart mitochondria 
led to the observation that the respiratory control ratio (RCR) was significantly decreased 
(p<0.05, n=5) in cardiac mitochondria from Dicer-/- mice compared with Dicer+/+ animals (Figure 
4E). Consistent with this observation demonstrating impairment in oxidative metabolism it was 
noted that lactate levels in the heart of Dicer-/- mice were significantly higher (Figure 4F; p<0.05, 
n=4).  Taken together, these findings demonstrate that Dicer deletion induced hypertrophy and 
loss of cardiac function of the adult heart is associated with mitochondrial dysfunction and 
oxidative stress.  
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Figure 4. (A) Time course of average % signal change in the region of interest (ROI). 
Logarithmic values of signal change (normalized to the initial signal at time=0) in the ROIs are 
plotted with respect to time. Decay rate constants were obtained from the slope of linear decay 
after peak. Line with black circles represent Dicer+/+ and line with grey circles represent Dicer-/-. 
(B) Bar-graph showing the measured rate constants of nitroxide reduction in the tissues. Data 
expressed as mean ± SD (n=3). (C) Thiobarbituric acid–reactive substances (TBARS), an 
indicator of lipid peroxidation was measured from Dicer+/+ and Dicer-/- hearts and was 
significantly higher in the later. Data expressed as mean ± SD (n=3) (D) Total GSSG to GSH 
ratio in Dicer+/+ mice heart compared to Dicer-/- heart.  Higher ratio indicates increased oxidative 
stress. Data expressed as mean ± SEM (n=3). (E) Respiratory coupling ratio (RCR) was 
significantly lower in Dicer-/- mice indicating mitochondrial dysfunction. Data expressed as 
mean ± SD (n=3). (F) Lactate levels measured in Dicer+/+ and Dicer-/- mice hearts. Lactate is 
significantly higher in Dicer-/- mice. Data expressed as mean ± SD (n=3).  
 
DISCUSSION 
Dicer deficiency is emerging as a key factor determining health outcomes in humans. Cardiac-
specific deletion of Dicer leads to defects in heart development and embryonic lethality1, 4. Loss 
of Dicer in the juvenile as well as adult myocardium induces hypertrophy, myofiber disarray, 
ventricular fibrosis and functional defects3. However, the underlying mechanisms remain unclear. 
A
y = -0.0744x
R2= 0.9861
y = -0.0963x
R2= 0.9962
-1.6
-1.4
-1.2
-1
-0.8
-0.6
-0.4
-0.2
0
0.00 5.00 10.00 15.00
time after injection (min)
ln
(in
te
n
si
ty
 
a
t t
im
e 
t) 
-
ln
(in
te
n
si
ty
 
a
t t
im
e
 
0)
B
*
0
40
80
120
160
Dicer +/+ Dicer -/-
ra
te
 
o
f E
PR
 
s
ig
n
a
l d
ec
ay
(%
 
ch
an
ge
)
F
la
c
ta
te
 
c
o
n
ce
n
tr
a
tio
n
*
0
40
80
120
160
(%
 
ch
an
ge
)
Dicer-/-Dicer+/+
D
0
50
100
150
200
250
Dicer+/+ Dicer-/-
G
SS
G
/G
SH
 
(%
 
ch
an
ge
)
*
0
40
80
120
160
Dicer+/+ Dicer-/-
TB
AR
S 
(%
 
ch
an
ge
) *
C
E
0
1.8
2.1
2.4
2.7
3.0
re
s
pi
ra
to
ry
 
c
o
n
tr
o
l r
a
tio
(st
at
e 
3/
s
ta
te
 
4)
*
Dicer+/+ Dicer-/-
ln
(in
te
n
si
ty
 
a
t t
im
e 
t) 
-
ln
(in
te
n
si
ty
 
a
t t
im
e
 
0)
ln
(in
te
n
si
ty
 
a
t t
im
e 
t) 
-
ln
(in
te
n
si
ty
 
a
t t
im
e
 
0)
ra
te
 
o
f E
PR
 
s
ig
n
a
l d
ec
ay
(%
 
ch
an
ge
)
ra
te
 
o
f E
PR
 
s
ig
n
a
l d
ec
ay
(%
 
ch
an
ge
)
la
c
ta
te
 
c
o
n
ce
n
tr
a
tio
n
(%
 
ch
an
ge
)
la
c
ta
te
 
c
o
n
ce
n
tr
a
tio
n
(%
 
ch
an
ge
)
G
SS
G
/G
SH
 
(%
 
ch
an
ge
)
G
SS
G
/G
SH
 
(%
 
ch
an
ge
)
TB
AR
S 
(%
 
ch
an
ge
)
re
s
pi
ra
to
ry
 
c
o
n
tr
o
l r
a
tio
(st
at
e 
3/
s
ta
te
 
4)
  
- 12 - 
The current work capitalizes on the observation that the onset of cardiac pathologies and 
dysfunction after conditional Dicer deletion in adult hearts is rapid such that overt functional 
deficiencies are manifested in the first week. miRNA profiling performed at such early time-
point helped identify the primary factors underlying cardiac dysfunction following Dicer 
deletion. The successful use of such information to develop a miRNA-based strategy to 
significantly rescue hearts from pathological changes caused by Dicer deletion provides first 
definitive evidence identifying a key miRNA-dependent pathway implicated in cardiac 
hypertrophy and dysfunction. Overt oxidative stress in Dicer-deficient hearts evident in this 
study pointed towards underlying mitochondrial dysfunction24-25. Indeed, studies with isolated 
mitochondria detected compromised RCR of mitochondria from Dicer-deficient hearts. ANTs 
export mitochondrial ATP into the cytosol and loss of ANT-1 expression has been recognized as 
a marker for mitochondrial dysfunction resulting in early cardiac dysfunction with later dilation 
and heart failure26. Our observation demonstrating lower ANT-1 in Dicer depleted hearts, 
support mitochondrial dysfunction as an underlying pathology. Mitochondrial energy deficiency 
is known to underlie dilated cardiomyopathy characterized by early mechanical dysfunction 
followed by a decline in left ventricular systolic function26. Hypertrophy and cardiac failure has 
often been associated with mitochondrial dysfunction and oxidative stress24, 27-29. The 
observation that Dicer-deletion in the adult heart caused early onset mitochondrial dysfunction 
led to the search for miRNA-dependent pathways targeting mitochondrial function in the heart. 
As we screened for miRNAs targeting mitochondrial function, elevated miRNA-15b emerged as 
a key candidate which is not only known to disrupt mitochondrial function Elevated miRNA-15b 
may also disrupt mitochondrial integrity by silencing ADP-ribosylation factor-like 2 (Arl2) 
therefore compromising cellular ATP levels30. Of interest, high miRNA-15b is known to be 
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associated with most common types of human heart failure5-6. Rescue experiments demonstrating 
that suppression of the rise of miRNA-15b in Dicer-deleted adult hearts result in marked 
amelioration of cardiac dysfunction definitively suggested a central role of miR-15b in 
determining cardiac mass and function. The significance of this observation is heightened by the 
reports demonstrating that miRNA-15b is elevated in most types of human heart failure5-6. Thus 
this study establishes the unique significance of miRNA-15b in determining cardiac metabolism 
and function. Interestingly, strategies to antagonize elevated miRNA-15b in the ailing heart may 
represent an efficient therapeutic approach which is worthy of consideration for clinical 
development.  
ACKNOWLEDGMENT 
Supported by R01 awards HL073087 and GM069589 to CKS. 
  
- 14 - 
 REFERENCES: 
1. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, 
McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac 
conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129(2):303-317. 
2. Saxena A, Tabin CJ. miRNA-processing enzyme Dicer is necessary for cardiac outflow 
tract alignment and chamber septation. Proc Natl Acad Sci U S A.107(1):87-91. 
3. da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van Oort RJ, Pinto YM, 
Molkentin JD, De Windt LJ. Conditional dicer gene deletion in the postnatal myocardium 
provokes spontaneous cardiac remodeling. Circulation. 2008;118(15):1567-1576. 
4. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond 
SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ. 
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. 
Proc Natl Acad Sci U S A. 2008;105(6):2111-2116. 
5. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular 
disease. Circulation.121(8):1022-1032. 
6. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and 
heart failure. Circ Res. 2008;103(10):1072-1083. 
7. Gnyawali SC, Roy S, McCoy M, Biswas S, Sen CK. Remodeling of the ischemia-
reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-
enhanced infarct patches and transmurality. Antioxid Redox Signal. 2009;11(8):1829-
1839. 
8. Zhu X, Zuo L, Cardounel AJ, Zweier JL, He G. Characterization of in vivo tissue redox 
status, oxygenation, and formation of reactive oxygen species in postischemic 
myocardium. Antioxid Redox Signal. 2007;9(4):447-455. 
9. Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM, 
Sen CK, Roy S. Macrophage dysfunction impairs resolution of inflammation in the 
wounds of diabetic mice. PLoS One. 2010;5(3):e9539. 
10. Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, Sen CK. Molecular basis 
of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-
induced neurodegeneration. The Journal of biological chemistry. 2003;278(44):43508-
43515. 
11. Khanna S, Roy S, Slivka A, Craft TK, Chaki S, Rink C, Notestine MA, DeVries AC, 
Parinandi NL, Sen CK. Neuroprotective properties of the natural vitamin E alpha-
tocotrienol. Stroke. 2005;36(10):2258-2264. 
12. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S. Oxidant-induced vascular 
endothelial growth factor expression in human keratinocytes and cutaneous wound 
healing. The Journal of biological chemistry. 2002;277(36):33284-33290. 
13. Chen YR, Chen CL, Pfeiffer DR, Zweier JL. Mitochondrial complex II in the post-
ischemic heart: oxidative injury and the role of protein S-glutathionylation. The Journal 
of biological chemistry. 2007;282(45):32640-32654. 
14. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. Endotoxin-induced mitochondrial 
damage correlates with impaired respiratory activity. Crit Care Med. 2002;30(2):276-284. 
15. Claycomb WC, Lanson NA, Jr., Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, 
Izzo NJ, Jr. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic 
characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95(6):2979-
2984. 
  
- 15 - 
16. Shilo S, Roy S, Khanna S, Sen CK. Evidence for the involvement of miRNA in redox 
regulated angiogenic response of human microvascular endothelial cells. Arterioscler 
Thromb Vasc Biol. 2008;28(3):471-477. 
17. Hussain SR, Cheney CM, Johnson AJ, Lin TS, Grever MR, Caligiuri MA, Lucas DM, 
Byrd JC. Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid 
malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-
dependent cytotoxicity. Clin Cancer Res. 2007;13(7):2144-2150. 
18. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. Mechanisms of 
acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial 
permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 
2005;312(2):509-516. 
19. Khanna S, Roy S, Parinandi NL, Maurer M, Sen CK. Characterization of the potent 
neuroprotective properties of the natural vitamin E alpha-tocotrienol. J Neurochem. 
2006;98(5):1474-1486. 
20. Roy S, Biswas S, Khanna S, Gordillo G, Bergdall V, Green J, Marsh CB, Gould LJ, Sen 
CK. Characterization of a preclinical model of chronic ischemic wound. Physiol 
Genomics. 2009;37(3):211-224. 
21. Roy S, Khanna S, Rink C, Biswas S, Sen CK. Characterization of the acute temporal 
changes in excisional murine cutaneous wound inflammation by screening of the wound-
edge transcriptome. Physiol Genomics. 2008;34(2):162-184. 
22. Roy S, Patel D, Khanna S, Gordillo GM, Biswas S, Friedman A, Sen CK. Transcriptome-
wide analysis of blood vessels laser captured from human skin and chronic wound-edge 
tissue. Proc Natl Acad Sci U S A. 2007;104(36):14472-14477. 
23. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, 
Molkentin JD. Temporally regulated and tissue-specific gene manipulations in the adult 
and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89(1):20-25. 
24. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart 
failure. Antioxid Redox Signal. 2006;8(9-10):1737-1744. 
25. Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in 
cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death 
Differ. 2008;15(3):521-529. 
26. Narula N, Zaragoza MV, Sengupta PP, Li P, Haider N, Verjans J, Waymire K, Vannan M, 
Wallace DC. Adenine nucleotide translocase 1 deficiency results in dilated 
cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and 
activation of apoptosis. Jacc.4(1):1-10. 
27. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac 
hypertrophy and heart failure. Heart. 2007;93(8):903-907. 
28. Tsutsui H. Mitochondrial oxidative stress and heart failure. Intern Med. 2006;45(13):809-
813. 
29. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to 
heart failure. J Am Coll Cardiol. 1996;28(2):506-514. 
30. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, 
Mori RT, Hasegawa K, Kita T, Kimura T. MicroRNA-15b modulates cellular ATP levels 
and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. The Journal of 
biological chemistry.285(7):4920-4930. 
 
